Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
M&AAllen & Overy Advise During HIG European Capital Partners' Acquisition of Centros Unico
NewsMark Roebuck, DPO and Founder of ProvePrivacy explains how companies struggling to keep up with data regulation adherence demands should look to internal Data Champions.
LeadershipThe tech sector is one of the most targeted for M&A activity, attracting a wide variety of cross-industry buyers.
LegalWhile not every buyout or merger includes noncompetes, understanding how to approach these clauses can be critical to successful deal-making.
InnovationWhen people say "innovation," most minds jump to technology—apps, AI, algorithms, and maybe something about blockchain.
LegalWKB Advise Aviva During Acquisition of Expander Advisors
FinanceAlternative Assets No Longer Considered Alternative
M&AMerrill Datasite Advise Fraser's Acquisition of Malmaison
M&AMedicinal cannabis Private Equity fund-vehicle JPD Capital has announced it has entered into a joint venture with Verdex Group to create and scale a medicinal cannabis start-up in Spain.
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
